Phil Borman, DSc

Placeholder Person Graphic
GSK
Director, Quality By Design Development Lead
Phil Borman is a Chartered Chemist with more than 22 years of experience in the pharmaceutical industry, having obtained a Masters in Chemistry from UMIST (Manchester) University, a Masters in Applied Statistics from De Montfort (Leicester) University and more recently a Doctor in Sciences for his work in pioneering and developing QbD approaches for analytical procedures (also from De Montfort University). Phil is currently a Director at GlaxoSmithKline where he is accountable for the development and implementation of Quality by Design for Small Molecules. Phil pioneered the adaptation of QbD principles to Analytical methods and has published widely in the field of Analytical Chemistry. He currently co-leads the EFPIA Analytical Lifecycle Management Team.